Clinical Trials Directory

Trials / Completed

CompletedNCT00241592

Vaporization as a Smokeless Cannabis Delivery System

Vaporization as a Smokeless Cannabis Delivery System: A Pilot Study

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
18 (planned)
Sponsor
Center for Medicinal Cannabis Research · Academic / Other
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

A study to evaluate the use of a vaporization system as a smokeless delivery system for inhaled marijuana.

Detailed description

Our primary objective is to evaluate the use of a vaporization system ( the Volcano) as a smokeless delivery system for inhaled marijuana. We will compare plasma levels of delta-9-tetrahydrocannabinol (THC), cannabinol, cannabidiol, and metabolites, including 11-OH-THC, in healthy volunteers after smoking \~400 mg each of approximately 1.8, 3.5, and 7% THC marijuana cigarettes (using the Foltin puff procedure) to those obtained when the same individuals inhale the vaporization product of the rest of the marijuana from the identical cigarette processed through the Volcano device. In addition to plasma levels, we will also compare the THC concentrations over an 8-hour time period, the subjective high experienced by the patients, and clinical evidence of cannabis effect by evaluating conjunctival hyperemia and heart rate. We will also compare the tolerability of the two methods of ingestion, and we will monitor expired carbon monoxide to evaluate whether the vaporizer reduces exposure to respiratory toxins.

Conditions

Interventions

TypeNameDescription
DRUGCannabis

Timeline

Start date
2004-08-01
Completion
2005-05-01
First posted
2005-10-19
Last updated
2007-06-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00241592. Inclusion in this directory is not an endorsement.